CAREER DEVELOPMENT COMPONENT OF THE UCLA-ICMIC. F.I. The UCLA-ICMIC Career Development Component has been, and will continue to be, a flexible program. Our goal is to train outstanding candidates who have an interest in the interdisciplinary interface of basic cancer research and/or clinical-translational studies with molecular imaging applications. At the end of their ICMIC support, we hope their training will contribute to careers that increase cancer discovery research or improve diagnosis, prediction of response to therapy and/or monitoring of therapy. We are as flexible as possible with regard to the spectrum of trainees that we will recruit and support. However, we make - as a condition of support from Career Development resources - a provision that recipients participate in didactic instruction either in Cancer Biology or in principles of Biological Imaging (or both!) if the review committee is of the opinion that the candidate has a deficiency that will not be corrected by laboratory participation alone. Our Internal Review Board, made up of our Research Component P.l.s (Drs. Hong Wu, Caius Radu, Antoni Ribas), Drs. Herschman and Phelps, and Drs. Owen Witte and Jonathan Braun review applications and select trainees. We will also require, as a condition of support, that individual trainees participate in portions (tailored to the individual) of a "curriculum" that includes specific courses, individual laboratory research group meetings, participation in Crump Institute for Molecular Imaging, Jonsson Comprehensive Cancer Center and Institute of Molecular Medicine internal seminars, and UCLA-ICMIC weekly research meetings. We will also request of trainees and their mentors that trainees receive some practical experience in all the imaging modalities available in our Specialized Resources. Our goal, in addition to a successful research project, will be that - at the conclusion of their support period - the trainees will be familiar with the fundamental principles of biological imaging and cancer biology, and expert in one or more areas of imaging and cancer research. While we will not expect trainees to have mastered radiosynthetic chemistry, mathematical reconstructions of tomographic images and all the other technologies required for their research in this interdisciplinary program, we will expect a working knowledge of all these areas and expertise in their areas of concentration.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-9)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Los Angeles
United States
Zip Code
Jiao, Jing; Ishikawa, Tomo-O; Dumlao, Darren S et al. (2014) Targeted deletion and lipidomic analysis identify epithelial cell COX-2 as a major driver of chemically induced skin cancer. Mol Cancer Res 12:1677-88
Jiao, Jing; Mikulec, Carol; Ishikawa, Tomo-o et al. (2014) Cell-type-specific roles for COX-2 in UVB-induced skin cancer. Carcinogenesis 35:1310-9
Shurell, Elizabeth; Tran, Linh M; Nakashima, Jonathan et al. (2014) Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients. BMC Cancer 14:827
Mongini, Patricia K A; Kramer, Jill M; Ishikawa, Tomo-O et al. (2014) Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice. Clin Immunol 153:79-90
Wilks, Moses Q; Knowles, Scott M; Wu, Anna M et al. (2014) Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging. J Nucl Med 55:1539-44
Schwarzenberg, Johannes; Czernin, Johannes; Cloughesy, Timothy F et al. (2014) Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy. Clin Cancer Res 20:3550-9
Wardak, Mirwais; Schiepers, Christiaan; Cloughesy, Timothy F et al. (2014) ¹?F-FLT ???and ¹?F-FDOPA PET kinetics in recurrent brain tumors. Eur J Nucl Med Mol Imaging 41:1199-209
Nathanson, David A; Armijo, Amanda L; Tom, Michelle et al. (2014) Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication. J Exp Med 211:473-86
Hirata, Kenji; Kobayashi, Kentaro; Wong, Koon-Pong et al. (2014) A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT. PLoS One 9:e105682
Escuin-Ordinas, Helena; Atefi, Mohammad; Fu, Yong et al. (2014) COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors. Mol Oncol 8:250-60

Showing the most recent 10 out of 184 publications